Flash FinanceUS
Market closed S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI filing briefs · archive

8-K filings in June 2026, explained

1,106 material Form 8-K filings that 909 companies we cover made with the SEC in June 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).

Clear

1 of 1,106 briefs matches

newest first · times in ET
VRDNViridian Therapeutics, Inc.\DE Jun 26, 6:18 PM ET

Viridian Therapeutics wins FDA approval for Lumvoa for thyroid eye disease

Positive product/contract Written later 7.018.01

The FDA approved Viridian Therapeutics' Lumvoa (veligrotug-vvze) for thyroid eye disease regardless of disease activity or duration, and the company plans to launch it immediately. The approval is Viridian's first FDA-approved product and first commercial product, a milestone that moves the company from development toward sales.

  • FDA approval announced June 26, 2026; Lumvoa is the first TED treatment with labeling covering both active and chronic TED
  • Launch planned immediately; physicians can prescribe Lumvoa tomorrow, per the press release
  • Lumvoa is given as five intravenous infusions over 12 weeks; infusion reactions reported in about 9% of patients
  • Conference call and webcast scheduled Monday, June 29, 2026 at 8:00 a.m. ET
Read the filing on SEC.gov ↗

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.

Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.